We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tests to Determine Best Chemotherapy

By MedImaging staff writers
Posted on 07 Feb 2005
By combining two methods for evaluating the effectiveness of anticancer chemotherapy, researchers have developed a rapid and sensitive system for selecting the most appropriate drug for an individual patient.

Investigators at the Yale School of Medicine (New Haven, CT, USA) have combined their apoptosis assay with the commercially available ChemoFX assay offered by Precision Therapeutics, Inc. More...
(Pittsburgh, PA, USA).

The ChemoFX assay determines whether a drug will stop tumor growth. Tumor cells are removed during a surgical or biopsy procedure, and the tumor-derived cells are grown in tissue culture. The cells are then treated with anticancer drugs, and the amount of tumor-derived cells killed by each drug is determined. The Yale apoptosis assay measures the ability of the drug to stimulate the process of cell death.

"These two new assays will take the guesswork out of cancer treatment,” explained Dr. Gil Mor, associate professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. "In patients with very limited time left to live, six months can feel like an eternity when they may have to start a whole new course of treatment if it proves ineffective. This test will help physicians predict whether a patient will respond to a specific drug, much like they test bacteria for sensitivity to antibiotics.”




Related Links:
Yale School of Medicine
Precision Therapeutics, Inc.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.